HCPCS code lookup

HCPCS Level II

C9073

Brexucabtagene autoleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Ask Rivvi

Code
C9073
Description
Brexucabtagene autoleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose

CMS HCPCS quarterly update

Try it on your own data today.

Free to start. Most teams are using it the same day.